Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

There are many mechanisms at work here, but the blood sugar increase is probably secondary to the weight gain, rather than ...

But here’s a little insider info: Ozempic’s just the show name. The real star? Semaglutide, the active ingredient doing all ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

MASH曾名为非酒精性脂肪性肝炎（NASH），是代谢功能障碍相关脂肪性肝病（MAFLD）的晚期形式。MASH是导致肝脏相关死亡的主要原因，对全球卫生系统造成日益加重的负担。此外，MASH患者，特别是那些具有更多代谢风险因素（高血压、合并2型糖尿病）的 ...

Semaglutide, the active ingredient in Ozempic, has shown promising results in weight loss and blood sugar management. But did ...

近日，一项发表在《新英格兰医学杂志》（NEJM）上的研究显示，司美格鲁肽（Semaglutide）不仅可以帮助减轻体重，还能够显著缓解与肥胖相关的膝关节炎疼痛，提升患者的日常活动能力。这项研究在11个国家进行，涵盖了约400名参与者，标志着抗肥胖药物 ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

Unsurprisingly, the patients taking the active semaglutide lost way more weight than their placebo counterparts — but they also experienced dramatic reductions in their pain scales, with an ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...